Strides Pharma shares fell 3% on 26 September after the company announced its plans to spin off its Contract Development and Manufacturing Organisation (CDMO) and...
Stride Pharma shares hit a 52-week high of Rs 522.75 on 15 September after its wholly owned subsidiary, Stride Pharma Global Pte. Ltd., received tentative...
Strides Pharma Science on Monday declared that it had entered a binding contract to sell the biologics Unit-3 manufacturing facility of its associate company Stelis...